Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hard-to-treat cancers: drug shows promise in advanced HER2-positive tumors

NCT ID NCT07124000

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times

Summary

This study looks at how well the drug T-DXd works in adults with advanced HER2-positive cancers that have spread and no longer respond to other treatments. About 100 people will take part, and researchers will track whether tumors shrink and how long the benefit lasts. The goal is to see if T-DXd can help control the disease in a real-world setting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Birmingham, Alabama, 35243, United States

  • Research Site

    RECRUITING

    Bullhead City, Arizona, 86442, United States

  • Research Site

    RECRUITING

    Casa Grande, Arizona, 85122, United States

  • Research Site

    RECRUITING

    San Diego, California, 92123, United States

  • Research Site

    RECRUITING

    Boulder, Colorado, 80309, United States

  • Research Site

    RECRUITING

    Coral Springs, Florida, 33065, United States

  • Research Site

    RECRUITING

    St. Petersburg, Florida, 33714, United States

  • Research Site

    RECRUITING

    West Palm Beach, Florida, 33401, United States

  • Research Site

    RECRUITING

    Decatur, Illinois, 62526, United States

  • Research Site

    RECRUITING

    Topeka, Kansas, 66604, United States

  • Research Site

    RECRUITING

    Durham, North Carolina, 27708, United States

  • Research Site

    RECRUITING

    Wilson, North Carolina, 27893, United States

  • Research Site

    RECRUITING

    Canton, Ohio, 44718, United States

  • Research Site

    RECRUITING

    Maumee, Ohio, 43537, United States

  • Research Site

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Research Site

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Research Site

    RECRUITING

    Dallas, Texas, 75390, United States

Conditions

Explore the condition pages connected to this study.